Patent · US Expired

Substrate analogs that substitute for lipid I as a substrate for MurG

US6413732B1 · kind B1 · utility

1Cited by
2References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 1999
Grant dateJul 2, 2002
Priority date
Expiry dateFeb 2, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S530/812
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

General methods for monitoring the activity of MurG, a GlcNAc transferase involved in bacterial cell wall biosynthesis, is disclosed. More particularly, the synthesis of simplified substrate analogs of Lipid I (the natural substrate for MurG), which function as acceptors for UDP-GlcNAc in an enzymatic reaction catalyzed by MurG, is described. Assays using the substrate analogs of the invention are further disclosed, which are useful for identifying a variety of other substrates, including inhibitors of MurG activity, for facilitating mechanistic and/or structural studies of the enzyme and for other uses. High throughput assays are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.